A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 21, Issue 2, 2005, Pages 60-66

  Nakashima, S ^b   Arai, S ^a   Mizuno, Y ^a   Yoshino, K ^a   Ando, S ^a   Nakamura, Y ^a   Sugawara, K ^a   Koike, M ^a   Saito, E ^a   Naito, M ^a   Nakao, M ^a   Ito, H ^a   Hamaoka, K ^a   Rai, F ^a   Asakura, Y ^a   Akamatu, M ^a   Fujimori, K ^a   Inao, M ^a   Imai, Y ^a   Ota, S ^a   Fujiwara, K ^a   Shiibashi, M ^b   more..

^a Department of Gastroenterology and Hepatology ^*

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIULCER AGENT; DICLOFENAC; HISTAMINE H2 RECEPTOR ANTAGONIST; LOXOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID; TICLOPIDINE; WARFARIN;

ADULT; ARTICLE; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL ENDOSCOPY; HUMAN; INCIDENCE; JAPAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; ULCER;

EID: 20444417453     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02476.x     Document Type: Article

References (13)

1. Sung JJ. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users? Aliment Pharmacol Ther 2004; 20(Suppl. 2): 65-70 [Review].
2. Dubois RW, Melmed GY, Henning JM, Laine L. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther 2004; 19: 197-208 [Review].
3. Scheiman J, Isenberg J. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers. Am J Med 1998; 105: 32S-38S [Review].
4. Shiokawa Y, En E, Saitoh T, et al. Epidemiological study on upper digestive injuries by non-steroidal anti-inflammatory drugs. J Jpn Rheum Assoc 1991; 31: 96-111.
5. Sugano K. [Gastritis and gastric ulcers/EBD-based strategy] Approaches to gastritis and gastric ulcers: strategy for the treatment of peptic ulcers while HP eradication therapy is widely used. Med Pract 2001; 18: 1954-60.
6. Nakamura K, Yakahi Y, Kurosawa S, et al. [NSAIDs and Gastrointestinal Tract] Clinical Study on NSAIDs-induced gastromucosal injuries. Clin Gastroenterol 1999; 14: 403-12.
7. Kelly JP, Kaufman DW, Jurgelon JM. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413-6.
8. Serrano P, Lanas A, Arroyo MT, Ferreira IJ. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16: 1945-53.
9. Graham DY, Agrawal NM, Roth SH. Prevention of NSAIDs-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988; 2: 1277-80.
10. Taha AS, Hadson N, Hawkey CJ, et al. Famotidine in the prevention of gastric and duodenal ulcers caused by non-steroidal antiinflaminatory drugs. New Engl J Med 1996; 334: 1435-9.
11. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with non-steroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAIDs-induced Ulcer Management (OMNIUM) Study Group. New Engl J Med 1998; 338: 727-34.
12. Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-73.
13. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-8.